| __timestamp | Apellis Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 5280000 |
| Thursday, January 1, 2015 | 13730311 | 7148000 |
| Friday, January 1, 2016 | 22978599 | 19594000 |
| Sunday, January 1, 2017 | 40303878 | 22894000 |
| Monday, January 1, 2018 | 105285576 | 50337000 |
| Tuesday, January 1, 2019 | 220968770 | 109450000 |
| Wednesday, January 1, 2020 | 299921000 | 90450000 |
| Friday, January 1, 2021 | 420869000 | 104128000 |
| Saturday, January 1, 2022 | 387236000 | 108630000 |
| Sunday, January 1, 2023 | 354387000 | 134951000 |
Unleashing the power of data
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) investments are pivotal. Over the past decade, Apellis Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc. have demonstrated significant commitment to innovation. Apellis Pharmaceuticals has consistently increased its R&D spending, peaking in 2021 with a 50-fold increase from 2014. This surge underscores their dedication to pioneering treatments. Meanwhile, Rhythm Pharmaceuticals has also shown a robust growth trajectory, with a 25-fold increase in R&D expenses over the same period. By 2023, Apellis's R&D investment was approximately 2.6 times that of Rhythm, highlighting their aggressive pursuit of breakthroughs. These investments are not just numbers; they represent the relentless pursuit of life-changing therapies. As these companies continue to push boundaries, their R&D efforts promise to shape the future of healthcare.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Bristol-Myers Squibb Company vs Apellis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Apellis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: Rhythm Pharmaceuticals, Inc. vs Veracyte, Inc.
Rhythm Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Rhythm Pharmaceuticals, Inc. vs Evotec SE